Trial Profile
Clinical trial of Tocilizumab for adult onset still disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2018
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Tocilizumab (Primary)
- Indications Adult-onset Still's disease
- Focus Therapeutic Use
- 12 Oct 2018 New trial record
- 02 Oct 2018 Primary endpoint has not been met. (Part 2: Proportion of Patients who achieved ACR 50% improvement at 12 weeks)
- 02 Oct 2018 Primary endpoint has not been met. (Part 1:Proportion of Patients who achieved ACR 50% improvement at 4 weeks.)